Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study

Messoud Ashina*, David Dodick, Peter J. Goadsby, Uwe Reuter, Stephen Silberstein, Feng Zhang, Julia R. Gage, Sunfa Cheng, Daniel D. Mikol, Robert A. Lenz

*Corresponding author af dette arbejde
86 Citationer (Scopus)
Plum Print visual indicator of research metrics
  • Citations
    • Citation Indexes: 121
    • Policy Citations: 10
  • Captures
    • Readers: 109
  • Mentions
    • News Mentions: 5
see details

Fingeraftryk

Dyk ned i forskningsemnerne om 'Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science